Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.
Michael BöttcherHans-Dirk DüngenVasile CorceaFrank DonathRainard FuhrPim GalGerd MikusDietmar TrenkMartin CoenenPhilippe Vieira PiresClaudia MaschkeAntonios Othon AliprantisNina BescheCorina BeckerPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2023)
ClinicalTrials.gov number, NCT03504982.